Drug Profile
BI 187004 CL
Alternative Names: BI-187004; BI-187004-CL; VTP-34072Latest Information Update: 19 May 2020
Price :
$50
*
At a glance
- Originator Vitae Pharmaceuticals
- Developer Boehringer Ingelheim Pharmaceuticals
- Class
- Mechanism of Action 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Type 2 diabetes mellitus